HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
about
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldCancer cells with irons in the fireEvidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical PopulationsIron and cancer: more ore to be mined.Dietary iron, iron homeostatic gene polymorphisms and the risk of advanced colorectal adenoma and cancer.Pathophysiological consequences and benefits of HFE mutations: 20 years of research.HFE gene variants, iron, and lipids: a novel connection in Alzheimer's diseaseIron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function.Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancerInsights into the pathogenesis and treatment of cancer from inborn errors of metabolism.Gastrins, iron homeostasis and colorectal cancerIron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunitiesC282Y-HFE gene variant affects cholesterol metabolism in human neuroblastoma cellsOh the irony: Iron as a cancer cause or cure?National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage aImpact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosisAnalysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM dataHemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participantsCellular iron metabolism in prognosis and therapy of breast cancer.Intestinal iron homeostasis and colon tumorigenesisToenail iron, genetic determinants of iron status, and the risk of gliomaPremenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.Review article: the iron overload syndromes.Diagnosis and treatment of hereditary hemochromatosis: an update.Dietary Iron and Colorectal Cancer Risk: A Review of Human Population Studies.Deferasirox has strong anti-leukemia activity but may antagonize theanti-leukemia effect of doxorubicin.Overview of iron metabolism in health and disease.The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune systemEffect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells.HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A.Haemochromatosis and gastrointestinal cancer.Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal TumorigenesisHFE polymorphisms affect survival of brain tumor patients.Iron: an emerging factor in colorectal carcinogenesis.HFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.H63D HFE polymorphisms are associated with increased disease duration and decreased muscle superoxide dismutase-1 expression in amyotrophic lateral sclerosis patients.Cancer risk in HFE C282Y homozygotes: results from the HUNT 2 study.Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma.
P2860
Q24620628-31BF5A8A-133D-4E56-B48D-268810892899Q26851312-20EBB583-82AD-4181-B4E6-F8521A908BB2Q28383815-46C04785-EA89-4CCD-9421-719324F0EA9FQ33677592-942F29C2-6570-4DD5-AD92-618FA3DDE478Q33705220-E029EE5A-6F45-405A-A317-2CF275AACE2AQ33815961-5E69C96B-4FAC-456F-9248-D3D2D5241CE4Q33861622-208A0407-2E4A-49FA-A47F-B2D092A5AFF0Q34449959-BC236506-E393-472E-8C64-4D62F4CD2197Q34612480-1F635DA8-4B9E-4F07-BFD2-582B6514FE3FQ34768395-C5AA93F1-5442-47A2-8371-DCE863DC8E59Q34810044-0BF614B0-1093-43DA-92B1-6E1C8FDB4094Q35034547-4F610B6F-BF97-457F-96EE-660111729A0DQ35095545-4C9185C8-E2F5-46DC-8426-C1380F6EE4B1Q35343242-22B7F4DE-8519-4BD1-A629-E191D346AAA1Q35549037-520A237E-05CF-4377-8F43-A4D62C0624F9Q35854466-FD6DB948-5565-4CC1-AF34-D3DAB34BB3B7Q36328507-176D3CF4-E778-4C42-9FF6-2F018011F7C1Q36895384-82645476-D630-457F-A546-F8DBBB56E33AQ37056971-57AC492B-7A6F-4146-B02E-8EF0E1B5F81EQ37077422-216E2053-5395-4D09-85B6-6350802335D5Q37083757-10999427-6181-4AB7-A255-2390CC8C6619Q37297023-68A96303-DF8E-478A-873A-C9FCCDC2C077Q37633508-8F4C2C07-5BE7-4477-9CCC-5006153448F2Q37686041-8ECAB589-CBB2-484E-9F8F-D7F9CE507AE4Q37990051-3DE3E078-8C90-4166-8569-0EB9C5D86267Q38132275-33081D33-1DBB-434B-B905-C414328CE89AQ38312691-1CD20393-96DA-43C5-BB13-DB19E06B79D9Q38763826-F5DD218E-2594-4B6C-BF67-3B0ADD562AD9Q39179833-63B23698-4B6C-40F1-ACB0-4D7BCE74D11BQ39285519-02FA0195-CA54-447E-A3E1-7246826A1F1EQ39606600-5F8E291F-0070-4E9B-870B-160B69F58D04Q39614785-E9926645-05DA-46E5-8005-EC64FE5E9B92Q40701829-49A5B532-915A-4214-81E4-DF27D3C80C96Q41093884-90F1B5F0-1C55-4196-9A80-A588DC363C78Q41709378-6F5C4823-59A5-49C7-A4B7-490B4E8FB975Q42922519-55D99240-444D-452B-8505-50C1959EC2A1Q44061467-7E1ED6A5-F5C2-495C-B06A-989F6F9E3541Q44112483-5A92292C-50E3-4E42-A1DA-43E17B49C6FCQ46308208-A189B8F7-B854-48B1-871F-40532931B517Q46478520-17C31CDA-CB46-4FD7-BDD2-953DD7E2C7CC
P2860
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
@en
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.
@nl
type
label
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
@en
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.
@nl
prefLabel
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
@en
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
@en
P2093
Christine E McLaren
Clare C Constantine
Dorota M Gertig
Lawrie W Powell
Martin B Delatycki
P2860
P304
P356
10.1002/HEP.23448
P407
P50
P577
2010-04-01T00:00:00Z